- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 127,540 | 29.07.24 20:00:28 | +2,280 | +1,82% | 127,530 | 127,550 | 127,235 | 125,260 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 106,430 | 29.07.24 19:58:40 | -0,710 | -0,66% | 105,910 | 106,430 | 107,290 | 107,140 |
